Your point of only one suitor if someone is indeed
Post# of 72440
I also missed in the PR that an oral form of K will actually " enhance the therapeutic benefits based on its pharmacokinetics, and broaden its market potential by meeting cancer patient’s strong preference for oral meds."
Just keeps getting better and better.